MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹47.75 | ₹32.00 | ₹35.78 | ₹31.59 | ₹25.72 |
What is the latest Earnings Per Share (EPS) of MANKIND PHARMA ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹47.75 |
| Mar2024 | ₹32.00 |
| Mar2023 | ₹35.78 |
| Mar2022 | ₹31.59 |
| Mar2021 | ₹25.72 |
How is Earnings Per Share (EPS) of MANKIND PHARMA Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹47.75 | 49.22 | |
| Mar2024 | ₹32.00 | -10.56 | |
| Mar2023 | ₹35.78 | 13.26 | |
| Mar2022 | ₹31.59 | 22.82 | |
| Mar2021 | ₹25.72 | - | |
Compare Earnings Per Share (EPS) of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹86,681.8 Cr | -6.4% | -3.4% | -16.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,905.0 Cr | -5.2% | -7.6% | -8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,357.0 Cr | -5.6% | -7.3% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,788.0 Cr | -0.6% | 4.8% | 25% | Stock Analytics | |
| CIPLA | ₹110,628.0 Cr | -4.5% | -9.7% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,441.5 Cr | -2.6% | -9.7% | -10.5% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -6.4% |
-3.4% |
-16.6% |
| SENSEX | -2.1% |
-3% |
6.8% |
You may also like the below Video Courses